Paroxysmal nocturnal haemoglobinuria: A replacement of haematopoietic tissue?

Acta Haematologica

Volumn 103, Issue 1, 2000, Pages 41-48

  Schrezenmeier, Hubert ^a   Hildebrand, Anette ^b   Rojewski, Markus ^a   Häcker, Hans ^b   Heimpel, Hermann ^b   Raghavachar, Aruna ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Aplastic anaemia; Glycosylphosphatidyl inositol anchor; Paroxysmal nocturnal haemoglobinuria; Pathophysiology; PIG A gene

Indexed keywords

CYCLOSPORIN A; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 3; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; FOLLOW UP; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034096753     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041003     Document Type: Article

References (45)

1. Tichelli A, Gratwohl A, Wursch A, et al: Late haematological complications in severe aplastic anaemia. Br J Haematol 1988;69:413-418.
2. Tichelli A, Gratwohl A, Nissen C, et al: Late clonal complications in severe aplastic anemia. Leuk Lymphoma 1994;12:167-175.
3. Rosse WF, Ware RE: The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995;86:3277-3286.
4. Luzzatto L, Bessler M: The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol 1996;3:101-110.
5. Schrezenmeier H, Hertenstein B, Wagner B, et al: A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol 1995;23:81-87.
6. Dunn DE, Tanawattanacharoen P, Boccuni P, et al: Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes (sec comments). Ann Intern Med 1999; 131:401-408.
7. Fores R, Alcocer M, Diez Martin JL, et al: Flow cytometric analysis of decay-accelerating factor (CD55) on neutrophils from aplastic anaemia patients. Br J Haematol 1995;90:728-730.
8. Griscelli Bennaceur A, Gluckman E, Scrobohaci ML, et al: Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link. Blood 1995;85:1354-1363.
9. Schubert J, Vogt HG, Ziclinska Skowronek M, et al: Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 1994;83:2323-2328.
10. Tooze JA, Saso R, Marsh JC, et al: The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia. Exp Hematol 1995;23:1484-1491.
11. Nissen C, Tichelli A, Gratwohl A, et al: High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia: A possible role of high endogenous IL-2 in their suppression. Acta Haematol 1999;101:165-172.
12. Rotoli B, Luzzatto L: Paroxysmal nocturnal haemoglobinuria. Baillières Clin Haematol 1989;2:113-138.
13. Rotoli B, Bessler M. Alfinito F, et al: Membrane proteins in paroxysmal nocturnal haemoglobinuria. Blood Rev 1993;7:75-86.
14. Young NS: The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood 1992;79:1385-1392.
15. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991;324:1297-1304.
16. Bacigalupo A, Hows J, Gluckman E, et al: Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA working party. Br J Haematol 1988;70: 177-182.
17. Raghavachar A, Ganser A, Freund M, et al: Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia. Cytokincs Mol Ther 1996;215-223.
18. Bessler M, Mason PJ, Hillmen P, et al: Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994;13:110-117.
19. Bessler M, Mason P, Hillmen P, et al: Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 1994;343: 951-953.
20. Bessler M, Mason PJ, Hillmen P, et al: Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1994;87:863-866.
21. Miyata T, Takeda J, Iida Y, et al: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993;259: 1318-1320.
22. Ostendorf T, Nischan C, Schubert J, et al: Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood 1995;85:1640-1646.
23. Takeda J, Miyata T, Kawagoe K, et al: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73:703-711.
24. Ware RE, Rosse WF, Howard TA: Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 1994;83: 2418-2422.
25. Yamada N, Miyata T, Maeda K, et al: Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995;85:885-892.
26. Endo M, Ware RE, Vreeke TM, et al: Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:2546-2557.
27. Lin LI, Liu CH, Chen YC, et al: PIG-A gene mutations in four Taiwanese patients with paroxysmal nocturnal haemoglobinuria following aplastic anaemia. Br J Haematol 1997;97:286-292.
28. Nafa K, Mason PJ, Hillmen P, et al: Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frame-shift type. Blood 1995;86:4650-4655.
29. Nagarajan S, Brodsky RA, Young NS, et al: Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995;86:4656-4661.
30. Nishimura J, Inoue N, Wada H, et al: A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones. Blood 1997;89:3470-3476.
31. Savoia A, Ianzano L, Lunardi C. et al: Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients. Hum Genet 1996;97:45-48.
32. Nakao S, Yamaguchi M, Takamatsu H, et al: Expansion of a paroxysmal nocturnal hemoglobinuria (PNH) clone after cyclosporine therapy for aplastic anemia/PNH syndrome (letter; comment). Blood 1992;80:2943-2944.
33. Hillmen P, Hows JM, Luzzatto L: Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1992;80:399-405.
34. van Kamp H, van Imhoff GW, de Wolf JT, et al: The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1995; 89:79-82.
35. Dacie J: Paroxysmal nocturnal haemoglobinuria. Sangre 1980;25:890-895.
36. Hillmen P, Bessler M, Luzzatto L, et al: Long-term follow-up of 80 patients with PNH: 11 of 32 patients surviving 10 years achieve spontaneous remission (abstract). Blood 1993;82 (suppl 1):310a.
37. Hillmen P, Lewis SM, Bessler M, et al: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-1258.
38. Kusminsky GD, Barazzutti L, Korin JD, et al: Complete response to antilymphocyte globulin in a case of aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome (letter). Am J Hematol 1988;29:123.
39. Nakakuma H, Nagakura S, Kawaguchi T, et al: Persistence of affected T lymphoctes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria. Blood 1994;84:3925-3928.
40. Iwamoto N, Kawaguchi T, Horikawa K, et al: Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. Blood 1996;87:4944-4948.
41. Kawagoe K, Kitamura D, Okabe M, et al: Glycosylphosphalidylinositol-anchor-deficient mice: Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:3600-3606.
42. Keller P, Tremml G, Rosti V, et al: X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci USA 1999;96:7479-7483.
43. Maciejewski JP, Sloand EM, Sato T, et al: Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria / aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood 1997;89:1173-1181.
44. Brett SJ, Baxter G, Cooper H, et al: Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1 treatment. Int Immunol 1996;8:325-334.
45. Hertenstein B, Wagner B, Bunjes D, et al: Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell Non-Hodgkin Lymphoma Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood 1995;86:1487-1492.